Prolog Biologicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 32.69%
- Profit Growth -58.40%
- Ebitda 2862.51%
- Net Worth 20.54%
- Total Assets 27.18%
About Prolog Biologicals
Prolog Biologicals Private Limited (PBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 23 May 2016 (Eight years and eight months 22 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Venkata Surakasi and Swapna Rekha serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999TG2016PTC109797
-
Company No.
109797
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 May 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Prolog Biologicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Surakasi
|
Director | 23-May-2016 | Current |
|
Swapna Rekha
|
Director | 23-May-2016 | Current |
Financial Performance of Prolog Biologicals.
Prolog Biologicals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 32.69% increase. The company also saw a substantial fall in profitability, with a 58.4% decrease in profit. The company's net worth Soared by an impressive increase of 20.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prolog Biologicals?
In 2019, Prolog Biologicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Aruna Wineries Private LimitedVenkata Surakasi and Swapna Rekha are mutual person
-
Aktachem Biotech Private Limited
Venkata Surakasi and Swapna Rekha are mutual person
-
Progenics Laboratories Private Limited
Venkata Surakasi and Swapna Rekha are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prolog Biologicals?
Unlock and access historical data on people associated with Prolog Biologicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prolog Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prolog Biologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.